Drug Development Against Covid-19
The COVID-19 pandemic has galvanized scientists and professionals across the globe to work together aimed at stopping the virus’ rampage and saving lives. This virus has a very dark side in all the pain and suffering. We at CAST-GNY hope through this pain and suffering it will bring the world closer together.
Concerning how we have been responding to the pandemic so far, it is especially vital now to help the public stay informed about medical research and drug trials for COVID-19, we at CAST-GNY are as committed as always to educating the public and accelerating better antiviral treatment and therapy against COVID-19.
We hope to invite you sincerely to our virtual event. We wanted to encourage you to join our fireside chat with our invited experts on July 12, 2020. At that time Dr. William Haseltine and Dr. Yaning Wang will share their insightful thoughts on the pivotal anti-COVID-19 drug development during the pandemic. Participants will have the opportunity to ask questions following an interactive discussion moderated by our guest facilitator Dr. Hua Lu and Vice President Jiayi Cheng.
Register for the event HERE.
William A. Haseltine PhD, Chair and President of ACCESS Health International
Designed the strategy to develop the first treatment for HIV/AIDS
One of “25 Most Influential Global Business Executives.”–TIMES Magazine
Yaning Wang, PhD, Director of the Division of Pharmacometrics in the Office of Clinical Pharmacology at FDA
Award of Merit and FDA Outstanding Service
Adjunct Professor in the Department of Pharmaceutics at the University of Florida
Hua Lu, MB (US MD Equivalent), PhD
Reynolds and Ryan Families Chair of Translational Cancer
Professor and Chair of the Department of Biochemistry and Molecular Biology